Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.
about
Clinical and experimental applications of sodium phenylbutyrateEpigenetic regulation of fetal globin gene expression in adult erythroid cellsShort-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activationA cell-based high-throughput screen for novel chemical inducers of fetal hemoglobin for treatment of hemoglobinopathiesInduction of human gamma globin gene expression by histone deacetylase inhibitorsInduction of fetal hemoglobin by propionic and butyric acid derivatives: correlations between chemical structure and potency of Hb F inductionFuture prospects for treatment of hemoglobinopathies.Butyrate increases the efficiency of translation of gamma-globin mRNA.Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo.Treatment of spinal muscular atrophy by sodium butyrate.Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor models.Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo.Pharmacotherapy in sickle cell disease--state of the art and future prospectsPharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.Histone Deacetylase Inhibitors Increase p27(Kip1) by Affecting Its Ubiquitin-Dependent Degradation through Skp2 DownregulationLiquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma.Effects of butyrate and glucocorticoids on gamma- to beta-globin gene switching in somatic cell hybrids.The therapeutic uses of chromatin-modifying agents.Modern treatment of thalassaemia intermedia.Histone deacetylase inhibitors and hemoglobin F induction in beta-thalassemiaImpact of epigenetic dietary compounds on transgenerational prevention of human diseases.Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.5'-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cellsBeta globin gene inhibition by antisense RNA transcripts.Novel treatment options in the severe beta-globin disorders.Stopping the biologic clock for globin gene switching.Sodium Butyrate and Valproic Acid as Splicing Restoring Agents in Erythroid Cells of β-Thalassemic Patients.Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate.Postnatal transition of gamma-globin gene expression in normal Japanese population.Novel approaches to treatment of sickle cell anaemia.Understanding fetal globin gene expression: a step towards effective HbF reactivation in haemoglobinopathies.Fetal lung mRNA levels of Hox genes are differentially altered by maternal diabetes and butyrate in rats.
P2860
Q24613511-23A0B0BF-CB0A-4671-A608-570A51FEFF58Q26864609-E9C1CA2C-E94B-4A28-80FA-A1B836DC7727Q28364488-748CFD66-8D38-4AF0-A35D-971F5A7A747AQ28542998-437A6226-2694-454B-B3C5-11A9FF08A398Q33598588-8CCDBE12-5F4C-4780-BBC4-B72F1CEFE27DQ33598612-523AED14-E0FE-4FBC-A90B-EDD24535BD14Q33606876-54164EB1-BFF4-4D6E-B7EB-7F02E3C5F20FQ33677601-8FF85483-41BA-41E6-B2D2-E6ED8921815CQ33922774-8443CCF0-373F-4967-9951-E604DC52EEBAQ33933841-0B2E9251-FA87-456E-A017-D4A3D6794A27Q34678844-7FD08ED7-0A79-4FB0-94DF-78984BFD72E0Q34723434-422546C3-9DAD-459C-9E9D-7AFA67D701E4Q34723868-D19300C8-69E6-4698-AEC5-3143F6704308Q35220342-1DC28C7B-8B17-4F4E-96D2-3EDDA7D96EA2Q35809469-B08D9215-15B1-4694-BC34-88D9E6F94320Q36349164-1E5C3D64-DED5-42A8-925F-E2CDE7E43E1BQ36478403-05315B0B-B9BB-4A79-B414-DB5ADF2A224CQ36566721-4CC1260B-C51A-4563-A1D8-62A4907FDFD5Q36822457-F6167D7F-4CBB-4A2F-A95E-D783D567480BQ36848269-966E50A4-F54A-48E4-ABB8-B949A6BD990FQ36968042-7CE68E33-9326-4D65-855C-18EE1F44B2E8Q37423737-3AD94213-307A-46BB-AFB8-194F3A45C1D0Q38025159-8DDC8252-008C-4B31-9D5B-877754D1EE85Q40640479-BAD6414A-5748-49EA-86C8-429947537011Q40897335-4366B11D-B500-49C7-8E8E-DB8A83CC5274Q40938157-ECFA447C-5415-465B-B3CE-025D349D878FQ41209359-FBF4F314-5C53-45CB-ADD5-DEEC91C836E8Q41674208-87E3365C-BD6E-4A49-A44D-C10DFA49B579Q42709676-8427262A-74E5-461A-9AF2-A5948B561D7BQ44066886-83B94C9C-430C-472C-83E0-EF443ECB4EDDQ45038164-C97B5375-B2E7-4E54-8FDE-DDE47DF5BA09Q45873795-061FA387-6349-4A8E-840D-04ECA3C6935DQ47720716-AC0BE239-092D-46CB-B32F-C848DFEE7295Q52185990-912DDC9E-EC92-476F-B8F7-5414A3560BBF
P2860
Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.
description
1988 nî lūn-bûn
@nan
1988 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.
@ast
Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.
@en
type
label
Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.
@ast
Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.
@en
prefLabel
Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.
@ast
Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.
@en
P2093
P2860
P356
P1476
Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.
@en
P2093
D V Faller
S P Perrine
P2860
P304
P356
10.1073/PNAS.85.22.8540
P407
P577
1988-11-01T00:00:00Z